骨髓间充质干细胞促进大鼠脑缺血后急慢性期小胶质细胞/巨噬细胞向M2型极化和神经发生
DOI:
作者:
作者单位:

浙江中医药大学基础医学院,杭州 310053,浙江,中国

作者简介:

通讯作者:

中图分类号:

基金项目:


Bone Marrow-derived Mesenchymal Stem Cells Promote Microglia/Macrophage M2 Polarization and Enhance Neurogenesis in the Acute and Chronic Stages after Ischemic Stroke
Author:
Affiliation:

Department of Physiology, Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    背景:缺血性脑卒中是世界范围内致死和致残的主要原因,目前尚缺乏有效的治疗方法。大量证据表明,在脑缺血损伤早期小胶质细胞极化为抗炎M2型,但随后逐渐转变为促炎M1型。骨髓间充质干细胞( Bone marrow-derived mesenchymal stem cells, BMSCs )可能通过调节脑卒中后炎症反应来减轻缺血性损伤。然而,其治疗缺血性脑卒中的机制尚不完全清楚。目的:本研究旨在观察大鼠局灶性脑缺血/再灌注损伤后,BMSCs能否促进小胶质细胞从M1型向M2型的表型转变并促进神经发生。方法:采用线栓法建立短暂性大鼠大脑中动脉阻塞模型,缺血90分钟再灌注。缺血后24小时尾静脉注射BMSCs,实验分假手术组、模型组、BMSCs治疗组。缺血后第1、3、7和14天进行神经功能评价;缺血后第3和14天分别采用qRT-PCR、双标记免疫荧光、Western blot检测小胶质细胞/巨噬细胞的M1/M2极化。缺血后第14天,采用BrdU/DCX双标记免疫荧光检测神经发生。缺血后第3和14天,采用免疫荧光法检测脑源性神经营养因子( brain-derived neurotrophic factor, BDNF )蛋白表达。结果:BMSCs治疗促进脑缺血后神经功能恢复,抑制M1型小胶质细胞/巨噬细胞标志物Tnfα, Nos2和CD16/32表达,增加M2型小胶质细胞/巨噬细胞标志物Il10, Tgfβ和CD206表达。此外,BMSCs治疗促进脑缺血后神经发生和M2型小胶质细胞源性BDNF表达。结论:BMSCs抑制脑缺血后神经炎症反应和促进神经发生,机制可能与其促进小胶质细胞/巨噬细胞从M1向M2型极化有关。

    Abstract:

    Background Ischemic stroke has been regarded as a major cause of disability and death around the world due to limited effective therapies. Accumulating evidence have shown that although microglia are polarized to an anti-inflammatory M2 phenotype in the early stage of ischemia, they transform progressively into a proinflammatory M1 phenotype. Bone marrow-derived mesenchymal stem cells (BMSCs) may be used to treat ischemic injury through regulating the poststroke inflammatory response. However, the mechanism by which BMSCs can treat ischemic stroke remains unclarified. Objective This study aimed to investigate whether BMSCs shift M1-to-M2 phenotype transformation of microglia/macrophages and enhance neurogenesis in a rat transient middle cerebral artery occlusion (tMCAO) model. Methods Ninety-minute tMCAO was applied to the rats, followed by reperfusion. BMSCs were transplanted into the rats via intravenous injection at 24 h after tMCAO. After being randomly divided into the sham group, the MCAO group, and the BMSCs group, the rats’ behavior was assessed at 1, 3, 7, and 14 days following tMCAO. qRT-PCR, double-immunofluorescence staining, and Western blot were performed at 3 and 14 days after tMCAO to determine M1/M2 polarization of microglia/macrophages. Neurogenesis was examined by double-immunofluorescence staining at 14 days after tMCAO. Expression of brain-derived neurotrophic factor (BDNF) was measured on the protein level by immunofluorescence staining at 3 and 14 days after tMCAO. Results We found that BMSCs treatment promoted the recovery of neurological function after tMCAO, inhibited the expression of TNFα, iNOS and CD16/32, which are markers of M1 microglia/macrophage, and enhanced the expression of IL10, TGFβ and CD206 that are markers of M2 microglia/macrophage. Moreover, BMSCs treatment promoted neurogenesis and M2-derived BDNF expression after tMCAO. Conclusion It is indicated by the results that BMSCs modulate neuroinflammation and enhance neurogenesis, which could be due to transforming microglia/macrophages from the M1 polarization state towards M2 in a rat tMCAO model.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-11-24
  • 出版日期: